Page last updated: 2024-08-17

bromodeoxyuridine and u-50488

bromodeoxyuridine has been researched along with u-50488 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duncan, MJ; Elde, RP; Gurwell, JA; Hauser, KF; Maderspach, K; Stiene-Martin, A	1
Cekanova, M; Dhar, MS; Plummer, HK; Schuller, HM	1

Other Studies

2 other study(ies) available for bromodeoxyuridine and u-50488

Article	Year
kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids. Brain research, 1996, Oct-21, Volume: 737, Issue:1-2 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Astrocytes; Benzeneacetamides; Bromodeoxyuridine; Calcium; Calcium Channel Blockers; Cell Count; Cell Division; Cells, Cultured; DNA; Enzyme Inhibitors; Gene Expression Regulation, Developmental; Immunohistochemistry; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Nifedipine; Phenotype; Pyrrolidines; Receptors, Opioid, kappa; Thapsigargin; Time Factors	1996
Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. BMC cancer, 2005, Aug-18, Volume: 5 Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Blotting, Western; Bromodeoxyuridine; Carcinoma, Small Cell; Cell Line, Tumor; Cell Proliferation; Cricetinae; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene Expression Regulation, Neoplastic; Humans; Isoproterenol; Lung Neoplasms; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Signal Transduction	2005

Article

Year

kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids.

Brain research, 1996, Oct-21, Volume: 737, Issue:1-2

Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Astrocytes; Benzeneacetamides; Bromodeoxyuridine; Calcium; Calcium Channel Blockers; Cell Count; Cell Division; Cells, Cultured; DNA; Enzyme Inhibitors; Gene Expression Regulation, Developmental; Immunohistochemistry; Mice; Mice, Inbred ICR; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Nifedipine; Phenotype; Pyrrolidines; Receptors, Opioid, kappa; Thapsigargin; Time Factors

1996

Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.

BMC cancer, 2005, Aug-18, Volume: 5

Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Blotting, Western; Bromodeoxyuridine; Carcinoma, Small Cell; Cell Line, Tumor; Cell Proliferation; Cricetinae; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene Expression Regulation, Neoplastic; Humans; Isoproterenol; Lung Neoplasms; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Signal Transduction

2005